[
  {
    "ts": "2025-09-02T15:13:28+00:00",
    "headline": "TD Cowen Affirms Buy Rating on Medtronic, Inc. (MDT) on RDN Therapy Prospects",
    "summary": "Medtronic plc (NYSE:MDT) is one of the top stock picks in Ken Griffin’s portfolio. On August 25, analysts at TD Cowen reiterated a ‘Buy’ rating on the stock and a $106 price target. The bullish stance comes as the research firm remains optimistic about the company’s coverage for renal denervation (RDN) therapy. The company’s letter […]",
    "url": "https://finance.yahoo.com/news/td-cowen-affirms-buy-rating-151328052.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "d4a3bf4c-02ce-315d-bc75-f4b0b6e31427",
      "content": {
        "id": "d4a3bf4c-02ce-315d-bc75-f4b0b6e31427",
        "contentType": "STORY",
        "title": "TD Cowen Affirms Buy Rating on Medtronic, Inc. (MDT) on RDN Therapy Prospects",
        "description": "",
        "summary": "Medtronic plc (NYSE:MDT) is one of the top stock picks in Ken Griffin’s portfolio. On August 25, analysts at TD Cowen reiterated a ‘Buy’ rating on the stock and a $106 price target. The bullish stance comes as the research firm remains optimistic about the company’s coverage for renal denervation (RDN) therapy. The company’s letter […]",
        "pubDate": "2025-09-02T15:13:28Z",
        "displayTime": "2025-09-02T15:13:28Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/5cc51fdb6ab9a0558fa4492bd6d1cddd",
          "originalWidth": 479,
          "originalHeight": 280,
          "caption": "TD Cowen Affirms Buy Rating on Medtronic, Inc. (MDT) on RDN Therapy Prospects",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/n65wYGKD1S_dYLnW4fWUzQ--~B/aD0yODA7dz00Nzk7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/5cc51fdb6ab9a0558fa4492bd6d1cddd.cf.webp",
              "width": 479,
              "height": 280,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wnV75zDdU4vB1oupaeGtkg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/5cc51fdb6ab9a0558fa4492bd6d1cddd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/td-cowen-affirms-buy-rating-151328052.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/td-cowen-affirms-buy-rating-151328052.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MDT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-02T15:06:54+00:00",
    "headline": "Medtronic advances Abbott partnership with FDA nod",
    "summary": "The company received FDA authorization to pair its 780G insulin pump with a glucose sensor made by Abbott, and to use the device for Type 2 diabetes.",
    "url": "https://www.medtechdive.com/news/medtronic-fda-authorize-780g-abbott/759049/",
    "source": "MedTech Dive",
    "provider": "yfinance",
    "raw": {
      "id": "37231ba8-87d9-34ef-b113-daebcd164dbc",
      "content": {
        "id": "37231ba8-87d9-34ef-b113-daebcd164dbc",
        "contentType": "STORY",
        "title": "Medtronic advances Abbott partnership with FDA nod",
        "description": "",
        "summary": "The company received FDA authorization to pair its 780G insulin pump with a glucose sensor made by Abbott, and to use the device for Type 2 diabetes.",
        "pubDate": "2025-09-02T15:06:54Z",
        "displayTime": "2025-09-02T15:06:54Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/medtech_dive_335/750fdf53cb35947d5f0ce8a43a826421",
          "originalWidth": 1280,
          "originalHeight": 720,
          "caption": "MedTech Dive, an Industry Dive publication",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CfiwZcqajD6GIrfQSU8QEw--~B/aD03MjA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/medtech_dive_335/750fdf53cb35947d5f0ce8a43a826421.cf.webp",
              "width": 1280,
              "height": 720,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jrfLJxLAsCtfuwsqFT5_ww--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/medtech_dive_335/750fdf53cb35947d5f0ce8a43a826421.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MedTech Dive",
          "url": "https://medtechdive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.medtechdive.com/news/medtronic-fda-authorize-780g-abbott/759049/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/medtronic-advances-abbott-partnership-fda-150654632.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MDT"
            },
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-02T12:45:00+00:00",
    "headline": "FDA Clears MiniMed™ 780G System to Enable Integration with the Instinct Sensor, Made by Abbott, and Approves Use in Type 2 Diabetes",
    "summary": "Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones that broaden the MiniMed™ 780G system portfolio: clearance of the SmartGuard™ algorithm as an interoperable automated glycemic controller (iAGC), enabling integration with the Instinct sensor, made by Abbott, for type 1 diabetes, and approval of the MiniMed™ 780G system for use in adults 18+ with insulin-requiring type 2 diabetes.",
    "url": "https://finance.yahoo.com/news/fda-clears-minimed-780g-system-124500754.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "1d8f9fb6-332c-394f-8ca2-d04331865931",
      "content": {
        "id": "1d8f9fb6-332c-394f-8ca2-d04331865931",
        "contentType": "STORY",
        "title": "FDA Clears MiniMed™ 780G System to Enable Integration with the Instinct Sensor, Made by Abbott, and Approves Use in Type 2 Diabetes",
        "description": "",
        "summary": "Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones that broaden the MiniMed™ 780G system portfolio: clearance of the SmartGuard™ algorithm as an interoperable automated glycemic controller (iAGC), enabling integration with the Instinct sensor, made by Abbott, for type 1 diabetes, and approval of the MiniMed™ 780G system for use in adults 18+ with insulin-requiring type 2 diabetes.",
        "pubDate": "2025-09-02T12:45:00Z",
        "displayTime": "2025-09-02T12:45:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/49a85cbd9b6b6669e9b3c414a6982ebf",
          "originalWidth": 400,
          "originalHeight": 225,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QANtiwB6KM2ndGTQsGitMQ--~B/aD0yMjU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/49a85cbd9b6b6669e9b3c414a6982ebf.cf.webp",
              "width": 400,
              "height": 225,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/34fkE8QSD5DJ_Y959l0WrQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/49a85cbd9b6b6669e9b3c414a6982ebf.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/fda-clears-minimed-780g-system-124500754.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/fda-clears-minimed-780g-system-124500754.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            },
            {
              "symbol": "MDT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-02T09:12:00+00:00",
    "headline": "UK Ligation Devices Market Analysis Report 2025-2033, with Profiles of Welfare Medical, Grena, Medtronic, Fannin, BioSpectrum, Teleflex, LocaMed, Johnson & Johnson, Boston Scientific, and more",
    "summary": "The UK ligation devices market promises growth due to rising chronic diseases, an aging population necessitating surgeries, and advancements in minimally invasive techniques. Demand for precise devices is rising, bolstered by NHS modernization and enhanced training, highlighting opportunities for innovation and adoption.Dublin, Sept. 02, 2025 (GLOBE NEWSWIRE) -- The \"UK Ligation Devices Market Size, Share & Trends Analysis Report By Product (Appliers, Accessories), By Application (Gastrointestin",
    "url": "https://finance.yahoo.com/news/uk-ligation-devices-market-analysis-091200214.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "d4c29ee6-acc9-3c52-baef-ffcf779f5601",
      "content": {
        "id": "d4c29ee6-acc9-3c52-baef-ffcf779f5601",
        "contentType": "STORY",
        "title": "UK Ligation Devices Market Analysis Report 2025-2033, with Profiles of Welfare Medical, Grena, Medtronic, Fannin, BioSpectrum, Teleflex, LocaMed, Johnson & Johnson, Boston Scientific, and more",
        "description": "",
        "summary": "The UK ligation devices market promises growth due to rising chronic diseases, an aging population necessitating surgeries, and advancements in minimally invasive techniques. Demand for precise devices is rising, bolstered by NHS modernization and enhanced training, highlighting opportunities for innovation and adoption.Dublin, Sept. 02, 2025 (GLOBE NEWSWIRE) -- The \"UK Ligation Devices Market Size, Share & Trends Analysis Report By Product (Appliers, Accessories), By Application (Gastrointestin",
        "pubDate": "2025-09-02T09:12:00Z",
        "displayTime": "2025-09-02T09:12:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc",
          "originalWidth": 480,
          "originalHeight": 58,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_MlAqEncKPaKK77zrkRGmQ--~B/aD01ODt3PTQ4MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc.cf.webp",
              "width": 480,
              "height": 58,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/caWFqk489OEmv3xI33JamQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/uk-ligation-devices-market-analysis-091200214.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/uk-ligation-devices-market-analysis-091200214.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MDT"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "BSX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]